Organoid Platform

Drug discovery and biotech · by Rosebud Biosciences

Mutation-specific organoid platform for drug screening.

What it does

Mutation-specific organoid platform for drug screening. Uses micropatterned 2.5D organoids from disease-specific hiPSCs to model genetic diseases, with support for cardiac, hepatic, neural (in progress), and kidney (in progress) organoid types.

  • Drug screening for rare genetic diseases
  • Targeted therapy development for pediatric genetic conditions
Category
Drug discovery and biotech
Built for
Agriculture and food production
Users
Pharma drug development teams, Researchers in heart, liver, neural, or kidney disease therapies
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Rosebud Biosciences doesn't list prices publicly. Ask them for a quote.

Security and compliance

No security details published yet

Rosebud Biosciences hasn't published certifications or security practices for Organoid Platform that we could find. Ask their team for audit reports.

Reviews

No reviews yet

Reviews come from people who use Organoid Platform at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim Organoid Platform